We recently reported that reduced expression of mismatch repair (MMR) genes MSH6/MSH2 directly promotes pituitary tumor proliferation via the ataxia telangiectasia and Rad3-related-checkpoint kinase 1 (ATR-Chk1) pathway [11,12]. The gene discussed is MSH2; the disease is pituitary tumor.